Niviron was founded in 2021. The company is based in Boston, Massachusetts, USA. The main goal of the company is to extend the humanlife span by advancement new technologies aimed at the treatment of oncological diseases. The company focuses on research in the field of cancer therapy with oncolytic viruses. Our attention is focused on the main approaches of viral cancer therapy: 1. Activation and targeting of the tumor by the immune system; 2. Destruction of cancer cells directly by an oncolytic virus; 3. Impact on the tumor microenvironment.